Back to search

Article

Oral Health Outcomes with GLP1 Receptor Agonists Compared with Other Metabolic Interventions

2026-08-24

Abstract excerpt

Semaglutide and tirzepatide are increasingly used for obesity and diabetes, producing substantial changes in appetite, dietary intake, body weight, glycemic control, and gastrointestinal physiology that could plausibly influence oral health. Reports of xerostomia and dental complications have emerged, but population-scale risk of new-onset oral disease remains unclear. Using de-identified electronic health records...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1f352ae0-df6c-5841-b7c4-41c30c5d553d
DOI
10.20944/preprints202608.1618.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Oral Health Outcomes with GLP1 Receptor Agonists Compared with Other Metabolic InterventionsDOI 10.20944/preprints202608.1618.v1
Phenome-wide analysis of downstream health outcomes following second-line antidiabetic agent prescriptions in All of Us.Semantic proximity
Neurosensory Risk After Semaglutide or Tirzepatide Is Lower Than Matched Antidiabetic and Bariatric Surgery Cohorts and Tracks Glycemic BurdenSemantic proximity
Association between oral health and bowel habits: a cross-sectional studySemantic proximity
Oral Wegovy Broadens Care Continuum Across First-Time GLP-Starters, High Cardiometabolic Burden GLP-Switchers, and Medicare-Age PatientsSemantic proximity
Greater lean-body-mass decline with tirzepatide than semaglutide in routine care, revealed by body-composition digital phenotypingSemantic proximity
Pharmacogenomics of GLP-1 Receptor Agonists: Precision Medicine in the Age of Ozempic and MounjaroSemantic proximity
Genetically Supported Drug Targets and Dental Traits: A Mendelian Randomization Study.Semantic proximity
Greater lean-body-mass decline with tirzepatide than semaglutide in routine care, revealed by body-composition digital phenotypingSemantic proximity
Dental manifestations in adult hypophosphatasia and their correlation with biomarkersSemantic proximity
Class-Wide Disproportionate Reporting of Impaired Gastric Emptying Across Nine Glucagon-Like Peptide-1 Receptor Agonist Products: A Signal-Detection Analysis of the FDA Adverse Event Reporting SystemSemantic proximity
Etiological Study on Changes in Oral Microbial Microenvironment Induced by Anti-Osteoclastic Drugs and Subsequent Development of MRONJSemantic proximity
Predictors of Functional Dentition in Adults: A Cross-Sectional Study Using Electronic Health RecordsSemantic proximity
Select a neighboring publication to make it the new centre.